Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Wellnex Life.
RELATED STOCKHEAD STORIES
Health & Biotech
Wellnex Life to rise 117pc in next 12 months forecasts Vested Equities
Experts
FREE WHELAN: Life, death, turkey and power
News
Deals Within Reach: From critical minerals to healthcare and everything in between
Health & Biotech
Wellnex to get Pain Away for lower upfront cost en route to London Listing
Health & Biotech
Wellnex expands supply agreement with Haleon to sell paracetamol products in UK, Ireland and UAE
Health & Biotech
Wellnex to buy leading Australian pain relief brand Pain Away for $22 million
News
Closing Bell: It’s a win for the ASX, loss for the newly unemployed as Aussie jobless rate rises
News
ASX Quarterly Wrap: Growing pipeline, milestones, and bullish guidance were the themes for these stocks
Health & Biotech
WEED WEEK: Wellnex teams up with Chemist Warehouse for new cannabis products
News
Which ASX micro caps have potential to grow exponentially through big partnership deals?
Health & Biotech
Wellnex Life joins forces with Chemist Warehouse to enter SAS-B medicinal cannabis market
Health & Biotech
Wellnex Life completes first delivery of Pharmacy Own products to leading pharmacy distributor CH2
Stockhead TV
2023 Prepped and Primed: Wellnex Life (ASX:WNX) with Executive Director and CEO, George Karafotias
Health & Biotech
Wellnex is a health and wellness darling as financials strengthen
Health & Biotech
Weed Week: Snoop Dogg releases Death Row Cannabis and Aussie player hits the German market
Health & Biotech
BIG Smiles as Wellnex Life finalises Mr. Bright deal
Stockhead TV
